Nuvigil Gets Protection Until 2023 Under New Patent

Composition-of-matter claim for “enantiomers of modafinil” adds a decade to the patent life of Cephalon’s follow-on wakefulness treatment.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet